Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,761.00
Bid: 1,757.50
Ask: 1,758.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.028%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-China jeweller Chow Tai Fook named in price-fixing probe-report

Fri, 19th Jul 2013 13:21

* Report says Chinese authorities investigating shops inShanghai

* Hong Kong-listed shares of jewellery companies slide

* Probe would mark latest business sector to come underscrutiny (Adds company statement)

By Yimou Lee and Twinnie Siu

HONG KONG, July 19 (Reuters) - Chow Tai Fook Jewellery GroupLtd, the world's biggest jewellery retailer by marketvalue, is among a number of gold shops being investigated forprice fixing, the online edition of the official People's Dailynewspaper reported.

An investigation would mark the latest sector to come underscrutiny in China as authorities also look into companies in theinfant formula milk and pharmaceutical industries.

Shares of Hong Kong-based Chow Tai Fook and other jewellerystores named in the report, including Chow Sang SangInternational Holdings Ltd, fell on the report.

In a statement posted on its website late on Friday, ChowTai Fook said it follows "its own gold pricing mechanism, and isnot subject to the constraints or restrictions of anyassociation or other jewellery retailers."

The People's Daily, citing unidentified sources, saidChina's National Development and Reform Commission was probingprice manipulation by some jewellery shops in the commercialcapital of Shanghai.

The online report, which was later reposted on a governmentwebsite, said several shops had admitted to authorities thatthey colluded on prices.

A spokeswoman for Chow Sang Sang, which has a market valueof $1.5 billion, told Reuters it did not know why it had beennamed in the report. "We don't understand why we got involved inthe story," spokeswoman Cathy Tam said.

"We set the gold price every day based on the New Yorkmarket close. The gold price is the same within the whole regionof China and we don't have district differences."

Chow Tai Fook has a market value of $11.9 billion. Itsmainland China revenue reached HK$30.3 billion ($3.9 billion) inthe year ended March 31, representing more than half of itstotal business. Eighty percent of its China business wascharacterised as retail.

Shanghai-based jewellery retailer Lao Feng Xiang, which was also named in the report, could notimmediately be reached for comment.

CORPORATE SCRUTINY EXPANDS

The report came days after Chinese authorities accusedBritain's top drug maker, GlaxoSmithKline, of bribingofficials and doctors to boost sales and raise medicine pricesthere, while Belgian drug maker UCB said on Thursday ithad also been visited by officials.

Pricing in the infant milk formula business is also underscrutiny and a number of international milk powder producersrecently cut prices in China after the country's top economicplanning agency said it was investigating possible price-fixingand anti-competitive behaviour.

Shares in Chow Tai Fook fell as much as 6 percent on Friday,while Chow Sang Sang shed as much as 5 percent.

Shares of firms not named in the report also fell, withEmperor Jewellery & Watch tumbling around 5 percentand Luk Fook Holdings (International) Ltd falling asmuch as 5 percent. The benchmark Hang Seng Index was flatin late afternoon trade.

Some analysts said pricing in the gold sector was generallytransparent and it would be hard to fix prices.

"Gold products are priced by weight and prices are difficultto manipulate because everyone knows the market and the pricesare very transparent. Also, if they mark up prices by too muchin Shanghai, consumers will buy their products elsewhere," saidSteve Chow, an analyst at Sunwah Kingsway Research.

Gold posted a record quarterly fall from April toJune, luring mainland Chinese buyers to Chow Tai Fook's almost1,800 jewellery and gold stores across China, Hong Kong andMacau.

Industry sources said it was market practice for majorjewellers to agree on a daily price benchmark for gold via thejewellery association and Chow Tai Fook might have been found tohave colluded with other players during this process.

The daily benchmark rates set by the association for goldproducts are between 13 and 15 percent higher than internationalgold prices to account for processing and craftsmanshipfees.

Chow Tai Fook earlier this month reported a 63 percent spikein first-quarter revenue, with sales of gold products from itsown stores soaring 78 percent in the quarter ended June 30.

($1 = 7.7580 Hong Kong dollars) (Additional reporting Lavinia Mo, Matthew Miller and NishantKumar in Hong Kong and Fayen Wong in Shanghai; Editing by ChrisGallagher and David Holmes)

More News
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.